Dong Mei Su
Director/Board Member at 3SBIO INC.
Net worth: 20 M $ as of 30/04/2024
Dong Mei Su active positions
| Companies | Position | Start | End |
|---|---|---|---|
| 3SBIO INC. | Director/Board Member | 11/06/2012 | - |
| Corporate Officer/Principal | 27/11/2014 | - | |
| SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD | Director/Board Member | 09/09/2022 | - |
| Liaoning Sunshine Bio-Pharmaceutical Co., Ltd. | Director/Board Member | 01/11/2006 | - |
| Liaoning Sunshine Science & Technology Development Co. Ltd. | Director/Board Member | 01/09/2009 | - |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
 Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | Director/Board Member | 01/01/1993 | - |
| Corporate Officer/Principal | 01/01/1993 | - | |
Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd.
 Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of 3SBio, Inc., Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd. is a Chinese bio-pharmaceutical company. The company is based in Dongguan, China. The company was founded in 2011. The CEO is Yong Xu. | Director/Board Member | 16/11/2018 | - |
Strategic International Group Ltd.
 Strategic International Group Ltd. Miscellaneous Commercial ServicesCommercial Services Strategic International Group Ltd. Provides financial services. The company is headquartered in London, the United Kingdom. | Director/Board Member | - | - |
Career history of Dong Mei Su
Former positions of Dong Mei Su
| Companies | Position | Start | End |
|---|---|---|---|
Hongkong Sansheng Medical Ltd.
 Hongkong Sansheng Medical Ltd. Pharmaceuticals: MajorHealth Technology Hongkong Sansheng Medical Ltd. develops and commercializes oral disintegration tablet formulation of antipruritic drug. The company is headquartered is Hong Kong. | Director/Board Member | 01/11/2009 | 01/11/2014 |
Guangdong Sunshine Pharmaceutical Co., Ltd.
 Guangdong Sunshine Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Founded in 2016, Guangdong Sunshine Pharmaceutical Co., Ltd. is a subsidiary of 3SBio, Inc. that manufactures and markets biopharmaceutical products. The company is based in Dongguan, China. | Director/Board Member | - | - |
Training of Dong Mei Su
| Jilin University | Undergraduate Degree |
| Shenyang Pharmaceutical University | Graduate Degree |
Statistics
International
| China | 10 |
| Hong Kong | 2 |
| United Kingdom | 2 |
Operational
| Director/Board Member | 9 |
| Corporate Officer/Principal | 2 |
| Graduate Degree | 1 |
Sectoral
| Health Technology | 7 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| 3SBIO INC. | Health Technology |
| SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD | Health Technology |
| Private companies | 7 |
|---|---|
Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd.
Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of 3SBio, Inc., Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd. is a Chinese bio-pharmaceutical company. The company is based in Dongguan, China. The company was founded in 2011. The CEO is Yong Xu. | Health Technology |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | Health Technology |
Hongkong Sansheng Medical Ltd.
Hongkong Sansheng Medical Ltd. Pharmaceuticals: MajorHealth Technology Hongkong Sansheng Medical Ltd. develops and commercializes oral disintegration tablet formulation of antipruritic drug. The company is headquartered is Hong Kong. | Health Technology |
Strategic International Group Ltd.
Strategic International Group Ltd. Miscellaneous Commercial ServicesCommercial Services Strategic International Group Ltd. Provides financial services. The company is headquartered in London, the United Kingdom. | Commercial Services |
Guangdong Sunshine Pharmaceutical Co., Ltd.
Guangdong Sunshine Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Founded in 2016, Guangdong Sunshine Pharmaceutical Co., Ltd. is a subsidiary of 3SBio, Inc. that manufactures and markets biopharmaceutical products. The company is based in Dongguan, China. | Health Technology |
| Liaoning Sunshine Bio-Pharmaceutical Co., Ltd. | |
| Liaoning Sunshine Science & Technology Development Co. Ltd. |
- Stock Market
- Insiders
- Dong Mei Su
- Experience
